+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Biomarker Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Cardiac Biomarker Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Cardiac Biomarker Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 92 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5770915
Description Jump to:
Cardiac biomarkers are measurable substances in blood that indicate heart conditions, such as troponin for myocardial infarction and NT-proBNP for heart failure. The market is driven by the high prevalence of cardiovascular diseases (CVDs), causing 17.9 million deaths annually, and an aging population projected to reach 2.1 billion by 2050. COVID-19 increased demand, with 16.4% of patients showing cardiac complications. High-sensitivity troponin tests and point-of-care (POC) devices like Abbott’s i-STAT enhance diagnostic speed. The global cardiac biomarkers market is estimated at USD 15-25 billion in 2025, with a CAGR of 12%-18% through 2030.

Regional Market Trends

  • North America: The U.S. leads with advanced diagnostics and high CVD prevalence, while Canada focuses on POC testing.
  • Europe: Germany, France, and the UK drive growth with digital health integration, emphasizing early diagnosis.
  • Asia Pacific: China and India see rapid demand due to rising CVD cases, with Japan prioritizing precision diagnostics.
  • Rest of the World: Brazil expands biomarker testing in public health, and the Middle East invests in cardiac care infrastructure.

Application Analysis

  • Laboratory Testing: Expected growth of 12.2%-18.2%, driven by high-throughput diagnostics. Trends focus on AI-driven analysis.
  • Point of Care Testing: Projected growth of 12.5%-18.5%, linked to rapid diagnostics in emergencies. Advances emphasize portable devices.

Type Analysis

  • Troponin: Expected growth of 12.7%-18.7%, valued for acute myocardial infarction diagnosis. Trends focus on high-sensitivity assays.
  • CK-MB: Projected growth of 11.8%-17.8%, used for early CVD detection. Advances emphasize specificity improvements.
  • Myoglobin: Anticipated growth of 11.5%-17.5%, suited for rapid testing. Trends highlight combination assays.
  • BNP and NT-proBNP: Expected growth of 12.3%-18.3%, critical for heart failure. Trends focus on risk stratification.
  • Others: Expected growth of 11.0%-17.0%, covering emerging biomarkers. Trends emphasize precision medicine.

Key Market Players

  • Roche: Offers high-sensitivity troponin assays.
  • Abbott: Provides POC testing devices.
  • Siemens Healthcare: Integrates AI for biomarker analysis.
  • Quidel Corporation: Focuses on rapid diagnostics.
  • BIOMÉRIEUX: Emphasizes cardiac infection markers.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, but innovation lowers entry hurdles.
  • Threat of Substitutes: Low, as imaging lacks biomarker specificity, though it complements diagnostics.
  • Bargaining Power of Buyers: Moderate, with hospitals seeking cost-effective tests, but clinical standards limit options.
  • Bargaining Power of Suppliers: Low, with multiple reagent providers.
  • Competitive Rivalry: High, with players competing on test sensitivity and speed.

Market Opportunities and Challenges

Opportunities:

  • Addressing CVDs, causing 17.9 million deaths annually.
  • Supporting an aging population with high CVD risk.
  • Leveraging COVID-19-driven demand for cardiac monitoring.
  • Utilizing high-sensitivity tests for faster diagnostics.
  • Aligning with WHO’s digital health strategy for standardization.
  • Enhancing precision medicine with risk stratification.

Challenges:

  • High costs of advanced assays and POC devices.
  • Regulatory delays, with FDA approvals taking 1-2 years.
  • Limited access in low-income regions.
  • False positives affecting test reliability.
  • Integration challenges with EHR systems.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Cardiac Biomarker Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Cardiac Biomarker Market in North America (2020-2030)
8.1 Cardiac Biomarker Market Size
8.2 Cardiac Biomarker Market by End Use
8.3 Competition by Players/Suppliers
8.4 Cardiac Biomarker Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Cardiac Biomarker Market in South America (2020-2030)
9.1 Cardiac Biomarker Market Size
9.2 Cardiac Biomarker Market by End Use
9.3 Competition by Players/Suppliers
9.4 Cardiac Biomarker Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Cardiac Biomarker Market in Asia & Pacific (2020-2030)
10.1 Cardiac Biomarker Market Size
10.2 Cardiac Biomarker Market by End Use
10.3 Competition by Players/Suppliers
10.4 Cardiac Biomarker Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Cardiac Biomarker Market in Europe (2020-2030)
11.1 Cardiac Biomarker Market Size
11.2 Cardiac Biomarker Market by End Use
11.3 Competition by Players/Suppliers
11.4 Cardiac Biomarker Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Cardiac Biomarker Market in MEA (2020-2030)
12.1 Cardiac Biomarker Market Size
12.2 Cardiac Biomarker Market by End Use
12.3 Competition by Players/Suppliers
12.4 Cardiac Biomarker Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Cardiac Biomarker Market (2020-2025)
13.1 Cardiac Biomarker Market Size
13.2 Cardiac Biomarker Market by End Use
13.3 Competition by Players/Suppliers
13.4 Cardiac Biomarker Market Size by Type
Chapter 14 Global Cardiac Biomarker Market Forecast (2025-2030)
14.1 Cardiac Biomarker Market Size Forecast
14.2 Cardiac Biomarker Application Forecast
14.3 Competition by Players/Suppliers
14.4 Cardiac Biomarker Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Cardiac Biomarker Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.2 Abbott
15.2.1 Company Profile
15.2.2 Main Business and Cardiac Biomarker Information
15.2.3 SWOT Analysis of Abbott
15.2.4 Abbott Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.3 Siemens Healthcare
15.3.1 Company Profile
15.3.2 Main Business and Cardiac Biomarker Information
15.3.3 SWOT Analysis of Siemens Healthcare
15.3.4 Siemens Healthcare Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.4 Quidel Corporation
15.4.1 Company Profile
15.4.2 Main Business and Cardiac Biomarker Information
15.4.3 SWOT Analysis of Quidel Corporation
15.4.4 Quidel Corporation Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.5 BIOMÉRIEUX
15.5.1 Company Profile
15.5.2 Main Business and Cardiac Biomarker Information
15.5.3 SWOT Analysis of BIOMÉRIEUX
15.5.4 BIOMÉRIEUX Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.6 Danaher
15.6.1 Company Profile
15.6.2 Main Business and Cardiac Biomarker Information
15.6.3 SWOT Analysis of Danaher
15.6.4 Danaher Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.7 Bio-Rad Laboratories
15.7.1 Company Profile
15.7.2 Main Business and Cardiac Biomarker Information
15.7.3 SWOT Analysis of Bio-Rad Laboratories
15.7.4 Bio-Rad Laboratories Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.8 Randox Laboratories
15.8.1 Company Profile
15.8.2 Main Business and Cardiac Biomarker Information
15.8.3 SWOT Analysis of Randox Laboratories
15.8.4 Randox Laboratories Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.9 Creative Diagnostics
15.9.1 Company Profile
15.9.2 Main Business and Cardiac Biomarker Information
15.9.3 SWOT Analysis of Creative Diagnostics
15.9.4 Creative Diagnostics Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.10 Life Diagnostics
15.10.1 Company Profile
15.10.2 Main Business and Cardiac Biomarker Information
15.10.3 SWOT Analysis of Life Diagnostics
15.10.4 Life Diagnostics Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
15.11 Thermo Fisher Scientific
15.11.1 Company Profile
15.11.2 Main Business and Cardiac Biomarker Information
15.11.3 SWOT Analysis of Thermo Fisher Scientific
15.11.4 Thermo Fisher Scientific Cardiac Biomarker Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Cardiac Biomarker Report
Table Data Sources of Cardiac Biomarker Report
Table Major Assumptions of Cardiac Biomarker Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Cardiac Biomarker Picture
Table Cardiac Biomarker Classification
Table Cardiac Biomarker Applications
Table Drivers of Cardiac Biomarker Market
Table Restraints of Cardiac Biomarker Market
Table Opportunities of Cardiac Biomarker Market
Table Threats of Cardiac Biomarker Market
Table COVID-19 Impact For Cardiac Biomarker Market
Table Raw Materials Suppliers
Table Different Production Methods of Cardiac Biomarker
Table Cost Structure Analysis of Cardiac Biomarker
Table Key End Users
Table Latest News of Cardiac Biomarker Market
Table Merger and Acquisition
Table Planned/Future Project of Cardiac Biomarker Market
Table Policy of Cardiac Biomarker Market
Table 2020-2030 North America Cardiac Biomarker Market Size
Figure 2020-2030 North America Cardiac Biomarker Market Size and CAGR
Table 2020-2030 North America Cardiac Biomarker Market Size by Application
Table 2020-2025 North America Cardiac Biomarker Key Players Revenue
Table 2020-2025 North America Cardiac Biomarker Key Players Market Share
Table 2020-2030 North America Cardiac Biomarker Market Size by Type
Table 2020-2030 United States Cardiac Biomarker Market Size
Table 2020-2030 Canada Cardiac Biomarker Market Size
Table 2020-2030 Mexico Cardiac Biomarker Market Size
Table 2020-2030 South America Cardiac Biomarker Market Size
Figure 2020-2030 South America Cardiac Biomarker Market Size and CAGR
Table 2020-2030 South America Cardiac Biomarker Market Size by Application
Table 2020-2025 South America Cardiac Biomarker Key Players Revenue
Table 2020-2025 South America Cardiac Biomarker Key Players Market Share
Table 2020-2030 South America Cardiac Biomarker Market Size by Type
Table 2020-2030 Brazil Cardiac Biomarker Market Size
Table 2020-2030 Argentina Cardiac Biomarker Market Size
Table 2020-2030 Chile Cardiac Biomarker Market Size
Table 2020-2030 Peru Cardiac Biomarker Market Size
Table 2020-2030 Asia & Pacific Cardiac Biomarker Market Size
Figure 2020-2030 Asia & Pacific Cardiac Biomarker Market Size and CAGR
Table 2020-2030 Asia & Pacific Cardiac Biomarker Market Size by Application
Table 2020-2025 Asia & Pacific Cardiac Biomarker Key Players Revenue
Table 2020-2025 Asia & Pacific Cardiac Biomarker Key Players Market Share
Table 2020-2030 Asia & Pacific Cardiac Biomarker Market Size by Type
Table 2020-2030 China Cardiac Biomarker Market Size
Table 2020-2030 India Cardiac Biomarker Market Size
Table 2020-2030 Japan Cardiac Biomarker Market Size
Table 2020-2030 South Korea Cardiac Biomarker Market Size
Table 2020-2030 Southeast Asia Cardiac Biomarker Market Size
Table 2020-2030 Australia Cardiac Biomarker Market Size
Table 2020-2030 Europe Cardiac Biomarker Market Size
Figure 2020-2030 Europe Cardiac Biomarker Market Size and CAGR
Table 2020-2030 Europe Cardiac Biomarker Market Size by Application
Table 2020-2025 Europe Cardiac Biomarker Key Players Revenue
Table 2020-2025 Europe Cardiac Biomarker Key Players Market Share
Table 2020-2030 Europe Cardiac Biomarker Market Size by Type
Table 2020-2030 Germany Cardiac Biomarker Market Size
Table 2020-2030 France Cardiac Biomarker Market Size
Table 2020-2030 United Kingdom Cardiac Biomarker Market Size
Table 2020-2030 Italy Cardiac Biomarker Market Size
Table 2020-2030 Spain Cardiac Biomarker Market Size
Table 2020-2030 Belgium Cardiac Biomarker Market Size
Table 2020-2030 Netherlands Cardiac Biomarker Market Size
Table 2020-2030 Austria Cardiac Biomarker Market Size
Table 2020-2030 Poland Cardiac Biomarker Market Size
Table 2020-2030 Russia Cardiac Biomarker Market Size
Table 2020-2030 MEA Cardiac Biomarker Market Size
Figure 2020-2030 MEA Cardiac Biomarker Market Size and CAGR
Table 2020-2030 MEA Cardiac Biomarker Market Size by Application
Table 2020-2025 MEA Cardiac Biomarker Key Players Revenue
Table 2020-2025 MEA Cardiac Biomarker Key Players Market Share
Table 2020-2030 MEA Cardiac Biomarker Market Size by Type
Table 2020-2030 Egypt Cardiac Biomarker Market Size
Table 2020-2030 Israel Cardiac Biomarker Market Size
Table 2020-2030 South Africa Cardiac Biomarker Market Size
Table 2020-2030 Gulf Cooperation Council Countries Cardiac Biomarker Market Size
Table 2020-2030 Turkey Cardiac Biomarker Market Size
Table 2020-2025 Global Cardiac Biomarker Market Size by Region
Table 2020-2025 Global Cardiac Biomarker Market Size Share by Region
Table 2020-2025 Global Cardiac Biomarker Market Size by Application
Table 2020-2025 Global Cardiac Biomarker Market Share by Application
Table 2020-2025 Global Cardiac Biomarker Key Vendors Revenue
Figure 2020-2025 Global Cardiac Biomarker Market Size and Growth Rate
Table 2020-2025 Global Cardiac Biomarker Key Vendors Market Share
Table 2020-2025 Global Cardiac Biomarker Market Size by Type
Table 2020-2025 Global Cardiac Biomarker Market Share by Type
Table 2025-2030 Global Cardiac Biomarker Market Size by Region
Table 2025-2030 Global Cardiac Biomarker Market Size Share by Region
Table 2025-2030 Global Cardiac Biomarker Market Size by Application
Table 2025-2030 Global Cardiac Biomarker Market Share by Application
Table 2025-2030 Global Cardiac Biomarker Key Vendors Revenue
Figure 2025-2030 Global Cardiac Biomarker Market Size and Growth Rate
Table 2025-2030 Global Cardiac Biomarker Key Vendors Market Share
Table 2025-2030 Global Cardiac Biomarker Market Size by Type
Table 2025-2030 Cardiac Biomarker Global Market Share by Type

Companies Mentioned

  • Roche
  • Abbott
  • Siemens Healthcare
  • Quidel Corporation
  • BIOMÉRIEUX
  • Danaher
  • Bio-Rad Laboratories
  • Randox Laboratories
  • Creative Diagnostics
  • Life Diagnostics
  • Thermo Fisher Scientific

Related Topics

Related Reports

Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Cardiac Biomarker Market by Biomarker Type, Clinical Setting, Application, End User - Global Forecast to 2030 - Product Image

Cardiac Biomarker Market by Biomarker Type, Clinical Setting, Application, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Cardiac Biomarker Diagnostic Kits Market by Biomarker Type, Indication, Testing Type, Purchasing Mode, Application, End User - Global Forecast to 2030 - Product Image

Cardiac Biomarker Diagnostic Kits Market by Biomarker Type, Indication, Testing Type, Purchasing Mode, Application, End User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Cardiac Biomarkers - Global Strategic Business Report - Product Image

Cardiac Biomarkers - Global Strategic Business Report

  • Report
  • 272 Pages
  • Global
From
Cardiac Biomarkers Market Report 2025 - Product Image

Cardiac Biomarkers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.